Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 7/20 | 1.00 |
| ▸ | TUBB4A | P04350 | 5/20 | 1.00 |
| ▸ | TUBB | P07437 | 5/20 | 1.00 |
| ▸ | TUBA3C | P0DPH7 | 5/20 | 1.00 |
| ▸ | TUBA1B | P68363 | 5/20 | 1.00 |
| ▸ | TUBA4A | P68366 | 5/20 | 1.00 |
| ▸ | TUBB4B | P68371 | 5/20 | 1.00 |
| ▸ | TUBB3 | Q13509 | 5/20 | 1.00 |
| ▸ | TUBB2A | Q13885 | 5/20 | 1.00 |
| ▸ | TUBB8 | Q3ZCM7 | 5/20 | 1.00 |
| ▸ | TUBA3E | Q6PEY2 | 5/20 | 1.00 |
| ▸ | TUBA1A | Q71U36 | 5/20 | 1.00 |
| ▸ | TUBA1C | Q9BQE3 | 5/20 | 1.00 |
| ▸ | TUBB6 | Q9BUF5 | 5/20 | 1.00 |
| ▸ | TUBB2B | Q9BVA1 | 5/20 | 1.00 |
| ▸ | TUBB1 | Q9H4B7 | 5/20 | 1.00 |
| ▸ | CYP2C9 | P11712 | 4/20 | 1.00 |
| ▸ | CYP2C19 | P33261 | 4/20 | 1.00 |
| ▸ | ABCB11 | O95342 | 2/20 | 1.00 |
| ▸ | CYP1A2 | P05177 | 2/20 | 1.00 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Noscapine SCHEMBL14386820 | 1.00 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL4559 | 1.00 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL29365828 | 1.00 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL10307295 | 1.00 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL2494164 | 1.00 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL12481369 | 1.00 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL14400084 | 1.00 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL1405962 | 0.99 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL29387578 | 0.99 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B | |
| Noscapine SCHEMBL177962 | 0.99 | CYP3A4 (1.00) | CYP3A4TUBB4ATUBBTUBA3CTUBA1B |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230248712-A1 | METHODS AND COMPOSITIONS FOR TREATING RNA VIRAL INFECTIONS | MODEL MEDICINES, INC. | 2023-08-10 | — | — | US | disclosed |
| US-11160773-B2 | Method for enhancing folding and transport of misfolded glucocerebrosidase | THE HOSPITAL FOR SICK CHILDREN (CA) | 2021-11-02 | — | — | US | disclosed |
| US-20200246282-A1 | Method for Enhancing Folding and Transport of Misfolded Glucocerebrosidase | THE HOSPITAL FOR SICK CHILDREN (CA) | 2020-08-06 | — | — | US | disclosed |
| US-10653645-B2 | Method for enhancing folding and transport of misfolded glucocerebrosidase | THE HOSPITAL FOR SICK CHILDREN (CA) | 2020-05-19 | — | — | US | disclosed |
| US-10028922-B2 | Method for enhancing folding and transport of misfolded glucocerebrosidase | THE HOSPITAL FOR SICK CHILDREN (CA) | 2018-07-24 | — | — | US | disclosed |
| US-10028922-B2 | Method for enhancing folding and transport of misfolded glucocerebrosidase | THE HOSPITAL FOR SICK CHILDREN (CA) | 2018-07-24 | — | — | US | disclosed |
| US-20170253898-A1 | NOSCAPINOID-PRODUCING MICROBES AND METHODS OF MAKING AND USING THE SAME | THE BOARD OF TRUSTEES OF THE LELAND STANFORD JUNIOR UNIVERSITY | 2017-09-07 | — | — | US | disclosed |
| US-20160331701-A1 | Method for Enhancing Folding and Transport of Misfolded Glucocerebrosidase | MCMASTER UNIVERSITY (CA) | 2016-11-17 | — | — | US | disclosed |
| US-20160331701-A1 | Method for Enhancing Folding and Transport of Misfolded Glucocerebrosidase | MCMASTER UNIVERSITY (CA) | 2016-11-17 | — | — | US | disclosed |
| US-9415025-B2 | Methods of treating Parkinson's disease | THE HOSPITAL FOR SICK CHILDREN (CA) | 2016-08-16 | — | — | US | disclosed |
| US-20130090388-A1 | METHOD OF TREATING GAUCHER DISEASE | MCMASTER UNIVERSITY (CA) | 2013-04-11 | — | — | US | disclosed |
| US-8124597-B2 | Method of treating gaucher disease | THE HOSPITAL FOR SICK CHILDREN (CA) | 2012-02-28 | — | — | US | disclosed |
| US-8124597-B2 | Method of treating gaucher disease | THE HOSPITAL FOR SICK CHILDREN (CA) | 2012-02-28 | — | — | US | disclosed |
| US-20120021487-A1 | METHOD OF TREATING GAUCHER DISEASE | MCMASTER UNIVERSITY (CA) | 2012-01-26 | — | — | US | disclosed |
| US-20120021487-A1 | METHOD OF TREATING GAUCHER DISEASE | MCMASTER UNIVERSITY (CA) | 2012-01-26 | — | — | US | disclosed |
| WO-2009038695-A1 | METHOD OF TREATING GAUCHER DISEASE | THE HOSPITAL FOR SICK CHILDREN (CA) | 2009-03-26 | — | — | WO | disclosed |
| US-20090075960-A1 | Method of treating gaucher disease | THE HOSPITAL FOR SICK CHILDREN (CA) | 2009-03-19 | — | — | US | disclosed |
| US-20090075960-A1 | Method of treating gaucher disease | THE HOSPITAL FOR SICK CHILDREN (CA) | 2009-03-19 | — | — | US | disclosed |
| US-20080267948-A1 | Croos-B Structure Binding Compounds | CROSSBETA BIOSCIENCES B.V. (NL) | 2008-10-30 | — | — | US | disclosed |
| US-20080267948-A1 | Croos-B Structure Binding Compounds | CROSSBETA BIOSCIENCES B.V. (NL) | 2008-10-30 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170253898-A1 | NOSCAPINOID-PRODUCING MICROBES AND METHODS OF MAKING AND USING THE SAME | NOS2, NISCH, NOS1 | CYP3A4 29/4885TUBB4A 954/4885TUBB 1594/4885 |
| US-20080267948-A1 | Croos-B Structure Binding Compounds | CACYBP, TBCB, MYCBP | CYP3A4 3998/4885TUBB4A 407/4885TUBB 162/4885 |
| US-20090075960-A1 | Method of treating gaucher disease | GBA1, GAA, GBA3 | CYP3A4 4590/4885TUBB4A 269/4885TUBB 182/4885 |
| US-20200246282-A1 | Method for Enhancing Folding and Transport of Misfolded Glucocerebrosidase | GBA1, GBA3, GAA | CYP3A4 4270/4885TUBB4A 957/4885TUBB 781/4885 |
| US-10653645-B2 | Method for enhancing folding and transport of misfolded glucocerebrosidase | GBA1, GBA3, GAA | CYP3A4 4270/4885TUBB4A 957/4885TUBB 781/4885 |
| US-11160773-B2 | Method for enhancing folding and transport of misfolded glucocerebrosidase | GBA1, GBA3, GAA | CYP3A4 4270/4885TUBB4A 957/4885TUBB 781/4885 |
| US-20130090388-A1 | METHOD OF TREATING GAUCHER DISEASE | GBA1, GAA, GBA3 | CYP3A4 4590/4885TUBB4A 269/4885TUBB 182/4885 |
| US-20160331701-A1 | Method for Enhancing Folding and Transport of Misfolded Glucocerebrosidase | GBA1, GBA3, GAA | CYP3A4 4270/4885TUBB4A 957/4885TUBB 781/4885 |
| US-10028922-B2 | Method for enhancing folding and transport of misfolded glucocerebrosidase | GBA1, GBA3, GAA | CYP3A4 4270/4885TUBB4A 957/4885TUBB 781/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.